Stockscreener 앱 받기
161.25
1.26%
-2.06
시간 외 거래:
161.25
전일 마감가:
$163.31
열려 있는:
$160.95
하루 거래량:
528.96K
Relative Volume:
0.62
시가총액:
$7.94B
수익:
$4.06B
순이익/손실:
$413.08M
주가수익비율:
20.13
EPS:
8.01
순현금흐름:
$560.48M
1주 성능:
-1.50%
1개월 성능:
-3.39%
6개월 성능:
-2.46%
1년 성능:
-18.46%
1일 변동 폭
$158.69
$162.44
1주일 범위
$158.69
$165.22
52주 변동 폭
$91.86
$230.02
Charles River Laboratories International Inc Stock (CRL) Company Profile
명칭
Charles River Laboratories International Inc
전화
781-222-6000
주소
251 BALLARDVALE ST, WILMINGTON, MA
CRL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRL
Charles River Laboratories International Inc
|
161.25 | 8.04B | 4.06B | 413.08M | 560.48M | 8.01 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-23 | 업그레이드 | Redburn Atlantic | Neutral → Buy |
| 2025-05-14 | 업그레이드 | TD Cowen | Hold → Buy |
| 2025-05-08 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-03-21 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-03-04 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-03-03 | 업그레이드 | Redburn Atlantic | Sell → Neutral |
| 2025-01-22 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-01-17 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-18 | 다운그레이드 | CLSA | Hold → Underperform |
| 2024-11-07 | 업그레이드 | CLSA | Underperform → Hold |
| 2024-10-23 | 개시 | CLSA | Underperform |
| 2024-10-14 | 개시 | Redburn Atlantic | Sell |
| 2024-10-07 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-10-01 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-08-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-08-08 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | 다운그레이드 | Argus | Buy → Hold |
| 2024-06-07 | 개시 | Mizuho | Neutral |
| 2024-06-06 | 개시 | Goldman | Buy |
| 2024-02-15 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-09-13 | 개시 | TD Cowen | Market Perform |
| 2023-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-02-23 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-01-12 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-09-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-08-04 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-05-24 | 개시 | Guggenheim | Neutral |
| 2022-04-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-04-07 | 개시 | Stephens | Overweight |
| 2022-02-17 | 재확인 | BofA Securities | Buy |
| 2022-02-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-02-17 | 재확인 | Deutsche Bank | Buy |
| 2022-02-17 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-17 | 재확인 | UBS | Buy |
| 2021-08-05 | 재개 | Credit Suisse | Neutral |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-09-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-07-01 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-05-13 | 업그레이드 | UBS | Neutral → Buy |
| 2020-04-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-02 | 개시 | Deutsche Bank | Buy |
| 2020-02-18 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-01-10 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-01-08 | 개시 | Wells Fargo | Overweight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-10-18 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-10 | 개시 | SVB Leerink | Outperform |
| 2019-04-30 | 재개 | Evercore ISI | Outperform |
| 2018-12-14 | 개시 | Deutsche Bank | Buy |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-08-23 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2018-07-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-06-15 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-02-14 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
Charles River Laboratories International Inc 주식(CRL)의 최신 뉴스
Applying Wyckoff theory to Charles River Laboratories International Inc. stockJuly 2025 Selloffs & Safe Capital Growth Tips - Newser
Published on: 2025-09-02 14:56:06 - Newser
Developing predictive dashboards with Charles River Laboratories International Inc. dataEarnings Overview Report & Free Technical Pattern Based Buy Signals - Newser
Leading vs lagging indicators on Charles River Laboratories International Inc. performanceJuly 2025 Spike Watch & Stepwise Trade Signal Implementation - Newser
Using AI based signals to follow Charles River Laboratories International Inc.Wall Street Watch & Long-Term Investment Growth Plans - Newser
Will Charles River Laboratories International Inc. benefit from geopolitical trendsWeekly Earnings Recap & Reliable Momentum Entry Alerts - خودرو بانک
Price momentum metrics for Charles River Laboratories International Inc. explainedTrade Ideas & Fast Moving Stock Watchlists - Newser
Does Charles River Laboratories International Inc. stock have upside surprise potentialWeekly Profit Summary & Weekly Return Optimization Plans - خودرو بانک
Is Charles River Laboratories International Inc. forming a breakout patternJuly 2025 Volume & Community Consensus Trade Signals - خودرو بانک
Can a trend reversal in Charles River Laboratories International Inc. lead to recoveryMarket Movement Recap & Fast Entry Momentum Alerts - Newser
How sentiment analysis helps forecast Charles River Laboratories International Inc. - Newser
Is Charles River Laboratories International Inc. stock bottoming outQuarterly Market Review & Community Consensus Trade Signals - Newser
Advanced analytics toolkit walkthrough for Charles River Laboratories International Inc.Earnings Growth Report & Risk Adjusted Buy/Sell Alerts - Newser
Tools to assess Charles River Laboratories International Inc.’s risk profileMarket Trend Report & Growth Oriented Trading Recommendations - Newser
Real time scanner hits for Charles River Laboratories International Inc. explainedDividend Hike & Safe Capital Growth Tips - Newser
Charles River Laboratories International Inc. stock volume spike explainedTrade Entry Summary & Real-Time Buy Zone Alerts - Newser
Regression analysis insights on Charles River Laboratories International Inc. performanceEarnings Recap Summary & Safe Investment Capital Preservation Plans - Newser
Institutional scanner results for Charles River Laboratories International Inc.July 2025 Levels & Precise Buy Zone Identification - Newser
What earnings revisions data tells us about BigBear.ai Holdings Inc. Equity WarrantTrade Entry Summary & High Conviction Buy Zone Picks - Newser
How to use a screener to detect Charles River Laboratories International Inc. breakoutsJuly 2025 News Drivers & Fast Entry Momentum Alerts - Newser
How to track smart money flows in Charles River Laboratories International Inc.Trade Signal Summary & Expert Approved Momentum Ideas - Newser
What is Charles River Laboratories International Inc. s 5 year growth outlookRate Hike & Daily Market Momentum Tracking - خودرو بانک
Technical analysis overview for Charles River Laboratories International Inc. stock - Newser
Risk vs reward if holding onto Charles River Laboratories International Inc.Price Action & Reliable Entry Point Trade Alerts - Newser
Is Charles River Laboratories International Inc. meeting your algorithmic filter criteria2025 Trading Volume Trends & Expert Curated Trade Setup Alerts - Newser
Charles River Stock May Benefit From Joining EASYGEN Consortium - sharewise.com
Using data filters to optimize entry into Charles River Laboratories International Inc.2025 Analyst Calls & Growth Focused Entry Reports - Newser
How high can Charles River Laboratories International Inc. stock goWeekly Stock Analysis & AI Based Trade Execution Alerts - Newser
Recap Report: Is Charles River Laboratories International Inc. likely to announce a buybackJuly 2025 Recap & Accurate Technical Buy Alerts - خودرو بانک
Published on: 2025-09-01 11:07:51 - Newser
Short interest data insights for Banco Santander S.A. Depositary ReceiptMarket Sentiment Review & Comprehensive Market Scan Reports - Newser
Stock Analysis | Charles River Laboratories International OutlookMixed Signals Amid Earnings Optimism - AInvest
Published on: 2025-08-31 21:05:47 - Newser
Visualizing Charles River Laboratories International Inc. stock with heatmapsQuarterly Portfolio Summary & AI Powered Market Entry Ideas - Newser
Charles River Laboratories International Inc. stock trendline breakdownMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
Charles River Laboratories International Inc. Reversal Rally May Surprise Bears2025 Fundamental Recap & Fast Exit/Entry Strategy Plans - beatles.ru
Analyzing Charles River Laboratories International Inc. with risk reward ratio charts2025 Retail Activity & Real-Time Volume Analysis - Newser
Building trade automation scripts for Charles River Laboratories International Inc.Buy Signal & Weekly Breakout Opportunity Watchlist - Newser
Has Charles River Laboratories International Inc. found a price floorPortfolio Return Report & Entry and Exit Point Strategies - Newser
What high frequency data says about Charles River Laboratories International Inc.Quarterly Trade Summary & Daily Technical Stock Forecast Reports - Newser
Will Charles River Laboratories International Inc. stock go up soonTrade Performance Summary & Low Risk Investment Opportunities - Newser
Combining price and volume data for Charles River Laboratories International Inc.July 2025 Action & Target Return Focused Picks - Newser
Published on: 2025-08-31 12:25:58 - Newser
Is it time to cut losses on Charles River Laboratories International Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - Newser
Is Charles River Laboratories International Inc. forming a bottoming baseJuly 2025 Final Week & Free Community Consensus Stock Picks - Newser
Charles River Laboratories International Inc (CRL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.76%
0.65%
자본화:
|
볼륨(24시간):